October 11, 2019 /

DPT Meeting: FDA Opening Remarks

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

DPT Meeting: FDA Opening Remarks

AGENDA

Opening Remarks

  • Janet Woodcock, MD, U.S. Food and Drug Administration
  • Billy Dunn, MD, U.S. Food and Drug Administration
2019 Duchenne Platform Trial Stakeholder Meeting,
Conferences & Meetings

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo